Test Bank for Lehne's Pharmacotherapeutics 3rd Edition Rosenthal (All Chapters 1-21) | Verified Answers | Updated 2026

TEST BANK Rw




Lehne’s Pharmacotherapeutics for Advanced Practice Nurses
Rw Rw Rw Rw Rw



and Physician Assistants
Rw Rw Rw




Laura D. Rosenthal, and Jacqueline Rosenjack Burchum
Rw Rw Rw Rw Rw Rw




3rd Edition
Rw

,Table of Contents
Rw Rw




Unit Rw01 RwIntroduction 1
Unit Rw02 RwBasic RwPrinciples Rwof RwPharmacology 6
Unit Rw03 RwDrug RwTherapy RwAcross Rwthe RwLife RwSpan 15
Unit Rw04 RwPeripheral RwNervous RwSystem RwDrugs 22
Unit Rw05 RwCentral RwNervous RwSystem RwDrugs 31
Unit Rw06 RwDrugs Rwfor RwPain 38
Unit Rw07 RwPsychotherapeutic RwDrugs 43
Unit Rw08 RwSubstance RwUse RwDisorders 51
Unit Rw09 RwDrugs RwThat RwAffect Rwthe RwHeart, RwBlood RwVessels, RwBlood, Rwand RwBlood RwVolume 59
Unit Rw10 RwDrugs Rwfor RwEndocrine RwDisorders 68
Unit Rw11 RwWomen’s RwHealth 73
Unit Rw12 RwMen’s RwHealth 78
Unit Rw13 RwAntiinflammatory, RwAntiallergic, Rwand RwImmunologic RwDrugs 83
Unit Rw14 RwDrugs Rwfor RwBone Rwand RwJoint RwDisorders 91
Unit Rw15 RwRespiratory RwTract RwDrugs 97
Unit Rw16 RwGastrointestinal RwDrugs 102
Unit Rw17 RwNutrition Rwand RwComplimentary RwTherapies 110
Unit Rw18 RwTherapy Rwof RwInfectious Rwand RwParasitic RwDiseases 116
Unit Rw19 RwCancer RwTherapy 140
Unit Rw20 RwDrugs Rwfor RwEyes, RwEars, Rwand RwSkin 145
Unit Rw21 RwDrugs RwTherapy Rwin RwAcute RwCare 152

,Test RwBank Rw- RwLehne’s RwPharmacotherapeutics Rwfor RwAdvanced RwPractice RwNurses Rw& RwPhysician RwAssistants, Rw3rd e
Rw(Rosenthal, Rw2021)

Unit 01: Introduction
Rw Rw

Rosenthal: Lehne's Pharmacotherapeutics for Advanced Practice Nurses and
Rw Rw Rw Rw Rw Rw Rw

Physician Assistants, 3rd Edition
Rw Rw Rw Rw




MULTIPLE RwCHOICE

1. A Rwpatient Rwdiagnosed Rwwith Rwchronic Rwpain Rwcalls Rwto Rwrequest Rwan Rwoxycodone
Rw(Oxycontin) Rwrefill. RwWhich Rwaction Rwshould Rwthe Rwprescriber Rwtake Rwinitially?

a. Fax Rwthe Rwrenewal Rworder Rwto Rwthe Rwpharmacy.
b. Arrange Rwto Rwschedule Rwan Rwappointment Rwwith Rwthe Rwpatient.
c. Verify Rwthe Rwpatient’s Rwadherence Rwto Rwthe Rwprescribed Rwdrug Rwregimen.
d. Determine Rwthe Rwpatient’s Rwcurrent Rwmedication Rwdosage Rwand Rwpain Rwlevel.
ANS: R w B
Schedule RwII Rwmedications Rware Rwnot Rweligible Rwfor Rwrefills, Rwand Rwprescriptions Rwmust Rwbe
Rwhandwritten. RwIt Rwis Rwimportant Rwto Rwverify Rwthe Rwpatient’s Rwadherence Rwto Rwthe Rwdrug

Rwregimen Rwand Rwdetermine Rwthe Rwcurrent Rwdosage Rwof Rwmedication Rwand Rwpain Rwlevel;

Rwhowever, Rwthis Rwcan Rwbe Rwaccomplished Rwby Rwscheduling Rwan Rwappointment Rwand

Rwevaluating Rwthe Rwpatient Rwin Rwperson.




2. A Rwmetered-dose Rwalbuterol Rwinhaler Rwis Rwprescribed Rwfor Rwasthma Rwmanagement. RwThe
Rwpatient Rwreports Rwfeeling Rwjittery Rwsometimes Rwwhen Rwtaking Rwthe Rwmedication, Rwand Rwdoes

Rwnot Rwfeel Rwthat Rwthe Rwmedication Rwis Rwalways Rweffective. RwWhich Rwaction Rwwill Rwthe

Rwprovider Rwtake Rwto Rwbest Rwminimize Rwpatient Rwrisks Rwand Rwmaximize Rwmedication

Rweffectiveness?

a. Ask Rwthe Rwpatient Rwto Rwdemonstrate Rwuse Rwof Rwthe Rwinhaler Rwand Rwassess Rweffectiveness.
b. Assess Rwthe Rwpatient’s Rwexposure Rwto Rwfirst- Rwand Rwsecond-hand Rwtobacco Rwsmoke.
c. Auscultate Rwthe Rwpatient's RwlRwunRwW
g RwWsoWu.
ndTsBaS
ndMo.bW
taS
in Rwother Rwrelevant Rwvital Rwsigns.
d. Decrease Rwthe Rwdosage Rwto Rwreduce Rwside Rweffects.
ANS: R w C
Assessing Rwand Rwevaluating Rwlung Rwsounds Rwas Rwwell Rwas Rwother Rwvital Rwsigns Rwhelps
Rwdetermine Rwthe Rwpatient's Rwphysical Rwresponse Rwto Rwthe Rwmedication Rwand Rwallows

Rwcomparison Rwto Rwthe Rwpatient's Rwbaseline Rwvital Rwsigns. RwAsking Rwthe Rwpatient Rwto

Rwdemonstrate Rwinhaler Rwuse Rwhelps Rwto Rwevaluate Rwthe Rwpatient’s Rwability Rwto Rwadminister Rwthe

Rwmedication Rwproperly Rwand Rwis Rwpart Rwof Rwan Rweffective Rwevaluation, Rwbut Rwis Rwnot Rwa Rwpriority

Rwintervention Rwbased Rwon Rwthe Rwpatient’s Rwcurrent Rwreport. RwAssessing Rwtobacco Rwsmoke

Rwexposure Rwhelps Rwdetermine Rwwhether Rwnondrug Rwtherapies, Rwsuch Rwas Rwsmoke Rwavoidance,

Rwcan Rwbe Rwused Rwas Rwan Rwadjunct Rwto Rwdrug Rwtherapy, Rwbut Rwdoes Rwnot Rwrelate Rwto Rwthe

Rwpatient’s Rwcurrent Rwproblem. RwRewriting Rwthe Rwprescription Rwto Rwdecrease Rwthe Rwdosage

Rwmay Rwaddress Rwthe Rwdegree Rwof Rwjitteriness Rwexperienced,

but Rwdoes Rwnot Rwaddress Rwthe Rwpatient’s Rwconcern Rwthat Rwthe Rwdrug Rwis Rwnot Rwalways Rweffective.

3. A Rwpatient Rwis Rwprescribed Rwmetronidazole Rwfor Rwbacterial Rwvaginosis. RwWhich Rwpatient
Rwhistory Rwfinding Rwwould Rwbe Rwmost Rwconcerning Rwto Rwthe Rwprovider?

a. The Rwpatient Rwhad Rwa Rwrecent Rwyeast Rwinfection.
b. There Rwis Rwa Rwfamily Rwhistory Rwof Rwcervical Rwcancer.
c. The Rwpatient Rwdrinks Rwtwo Rwglasses Rwof Rwwine Rwevery Rwnight.
d. The Rwpatient Rwis
unemployed. RwANS: R w C
Rw




1 Rw| RwP Rwa
Rwg Rwe

, Test RwBank Rw- RwLehne’s RwPharmacotherapeutics Rwfor RwAdvanced RwPractice RwNurses Rw& RwPhysician RwAssistants, Rw3rd e
Rw(Rosenthal, Rw2021)

Patients Rwtaking Rwmetronidazole Rwshould Rwbe Rweducated Rwnot Rwto Rwdrink Rwalcohol Rwto
Rwprevent Rwa Rwdisulfiram-like Rwreaction. RwIt Rwwould Rwbe Rwconcerning Rwthat Rwthe Rwpatient

Rwdrinks Rwwine Rwdaily. RwHistory Rwof Rwa Rwyeast Rwinfection Rwmay Rwindicate Rwincreased Rwrisk Rwfor

Rwrecurrence Rwwith Rwadministration Rwof Rwan Rwantimicrobial. RwA Rwfamily Rwhistory Rwof Rwcervical

Rwcancer Rwis Rwnot Rwrelated Rwto Rwadministration Rwof Rwmetronidazole. RwUnemployment Rwcan

Rwindicate Rwlack Rwof Rwinsurance Rwcoverage, Rwwhich Rwmay Rwlimit Rwthe Rwpatient’s Rwability Rwto

Rwpurchase Rwmedications; Rwhowever, Rwgeneric Rwmetronidazole Rwis Rwone Rwof Rwthe Rwless

Rwexpensive Rwmedications.




4. The Rwprovider Rwprepares Rwa Rwpatient Rwwith Rwnewly Rwdiagnosed Rwtype Rw1 Rwdiabetes Rwfor
Rwhospital Rwdischarge. RwWhich Rwaction Rwby Rwthe Rwprovider Rwwill Rwbest Rwsupport Rwthe Rwpatient’s

Rwability Rwto Rweffectively Rwmanage Rwmedication Rwtherapy?

a. Asking Rwthe Rwpatient Rwto Rwdemonstrate Rwhow Rwto Rwmeasure Rwand Rwadminister Rwinsulin
b. Discussing Rwmethods Rwof Rwstoring Rwinsulin Rwand Rwdiscarding Rwsyringes
c. Giving Rwinformation Rwabout Rwhow Rwdiet Rwand Rwexercise Rwaffect Rwinsulin Rwrequirements
d. Teaching Rwthe Rwpatient Rwabout Rwthe Rwlong-term Rwconsequences Rwof Rwpoor Rwdiabetes Rwcontrol
ANS: R w A
Because Rwinsulin Rwmust Rwbe Rwgiven Rwcorrectly Rwto Rwcontrol Rwsymptoms Rwand Rwprevent Rwan
Rwoverdose, Rwit Rwis Rwmost Rwimportant Rwfor Rwthe Rwpatient Rwto Rwknow Rwhow Rwto Rwmeasure Rwand

Rwadminister Rwit. RwAsking Rwfor Rwa Rwdemonstration Rwof Rwtechnique Rwis Rwthe Rwbest Rwway Rwto

Rwdetermine Rwwhether Rwthe Rwpatient Rwhas Rwunderstood Rwthe Rwteaching. RwThe Rwother Rwteaching

Rwpoints Rware Rwimportant Rwas Rwwell, Rwbut Rwthey Rware Rwnot Rwas Rwcritical.




5. A Rwpatient Rwreports Rwthat Rwa Rwmedication Rwprescribed Rwfor Rwrecurrent Rwmigraine
Rwheadaches Rwis Rwnot Rwworking. RwWhich Rwaction Rwis Rwthe Rwprescriber’s Rwpriority Rwwhen

Rwaddressing Rwthe Rwpatient's Rwconcern?

a. Ask Rwthe Rwpatient Rwabout Rwthe Rwnumber Rwand Rwfrequency Rwof Rwtablets Rwtaken.
b. Assess Rwthe Rwpatient’s Rwheadache Rwpain Rwon Rwa Rwscale Rwfrom Rw1 Rwto Rw10.
c. PrescribeRwaRwnewRwmedicationWfW orWm.iT
grBaiSnM
e Rw.
mW anSagement.
d. Suggest Rwbiofeedback Rwas Rwan Rwadjunct Rwto Rwdrug Rwtherapy.
ANS: R w A
When Rwevaluating Rwthe Rweffectiveness Rwof Rwa Rwdrug, Rwit Rwis Rwimportant Rwto Rwdetermine Rwhow
Rwoften Rwthe Rwpatient Rwis Rwusing Rwthe Rwdrug. RwAsking Rwthe Rwpatient Rwto Rwidentify Rwhow Rwmany

Rwtablets Rware Rwtaken Rwand Rwhow Rwoften Rwhelps Rwthe Rwprovider Rwdetermine Rweffective Rwdosages

Rwand Rwadherence Rwto Rwthe Rwmedication Rwregimen. RwThe Rwpatient Rwhas Rwalready Rwstated Rwthat

Rwthe Rwmedication Rwis Rwnot Rwworking; Rwthe Rwactual Rwlevel Rwof Rwpain Rwmay Rwdetermine Rwthe

Rwdegree Rwto Rwwhich Rwit Rwis Rwnot Rwworking, Rwbut Rwit Rwdoes Rwnot Rwhelp Rwthe Rwprovider Rwto

Rwdetermine Rwwhy Rwit Rwis Rwnot Rwworking. RwThe Rwassessment Rwprocess Rwshould Rwgather Rwas

Rwmuch Rwinformation Rwabout Rwcompliance, Rwsymptoms, Rwand Rwdrug Rweffectiveness Rwas

Rwpossible Rwbefore Rwenacting Rwa Rwchange Rwin Rwtreatment. RwBiofeedback Rwmay Rwbe Rwan

Rweffective Rwadjunct Rwto Rwtreatment, Rwbut Rwit Rwshould Rwnot Rwbe Rwrecommended Rwwithout

Rwcomplete Rwinformation Rwabout Rwdrug Rweffectiveness.




6. The Rwdrug Rwmanual Rwstates Rwthat Rwolder Rwadult Rwpatients Rware Rwat Rwincreased Rwrisk Rwfor
Rwhepatotoxicity. RwWhich Rwaction Rwis Rwmost Rwimportant Rwwhen Rwprescribing Rwthis Rwmedication

Rwto Rwan Rw80-year-old Rwpatient?

a. Obtaining Rwbaseline Rwliver Rwfunction Rwstudies
b. Ensuring Rwthat Rwthe Rwdrug Rwis Rwtaken Rwin Rwthe Rwcorrect Rwdose Rwat Rwthe Rwcorrect Rwtime
c. Discontinuing Rwthe Rworder; Rwthe Rwdrug Rwis Rwcontraindicated Rwfor Rwthis Rwpatient
d. Giving Rwthe Rwmedication Rwintravenously Rwto Rwavoid Rwfirst Rwpass
metabolism RwANS: R w A
Rw


2 Rw| RwP Rwa
Rwg Rwe